Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$508K Buy
4,224
+86
+2% +$9.93K 0.01% 172
2025
Q4
$436K Buy
4,138
+9
+0.2% +$845 0.01% 146
2025
Q3
$347K Buy
4,129
+328
+9% +$27K 0.01% 158
2025
Q2
$301K Sell
3,801
-349
-8% -$27.7K 0.01% 161
2025
Q1
$373K Buy
4,150
+1,970
+90% +$184K 0.01% 141
2024
Q4
$217K Buy
2,180
+206
+10% +$21.2K 0.01% 174
2024
Q3
$224K Hold
1,974
0.01% 172
2024
Q2
$244K Buy
1,974
+274
+16% +$35.3K 0.01% 165
2024
Q1
$224K Buy
+1,700
New +$210K 0.01% 171
2023
Q3
Sell
-1,762
Closed -$203K 172
2023
Q2
$203K Buy
+1,762
New +$200K 0.01% 163
2020
Q1
Sell
-4,491
Closed -$390K 146
2019
Q4
$390K Buy
+4,491
New +$369K 0.02% 127
2019
Q3
Sell
-2,620
Closed -$210K 133
2019
Q2
$210K Buy
+2,620
New +$201K 0.01% 126
2017
Q4
Sell
-3,734
Closed -$228K 120
2017
Q3
$228K Buy
+3,734
New +$226K 0.01% 112

Other funds holding MRK

Alesco Advisors's MRK Position: Q1 2026 in Review

Alesco Advisors increased its Merck (MRK) stake by 2.1% in Q1 2026, buying an estimated $9.93K and bringing the position to 4,224 shares worth $508K. The position accounts for 0.01% of the portfolio, ranked #172.

Alesco Advisors first reported a position in MRK in Q3 2017 and has held it in 13 quarters since. 3,781 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Alesco Advisors held 4,224 shares of Merck worth $508K as of Q1 2026.
  • Alesco Advisors bought 86 Merck shares in Q1 2026, an estimated $9.93K.
  • Merck made up 0.01% of Alesco Advisors's portfolio in Q1 2026, its #172 holding.
  • Alesco Advisors first reported a position in Merck in Q3 2017 and has held it in 13 quarters since.
  • 3,781 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Alesco Advisors's 13F filing for Q1 2026, filed 13 May 2026.